Title : Bleeding complications with platelet glycoprotein IIb/IIIa receptor antagonists.

Pub. Date : 1999 Sep

PMID : 10468150






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients undergoing percutaneous coronary interventions with adjunctive GPIIb/IIIa inhibition, the risk of bleeding, particularly from the femoral vascular access site, may be reduced through the use of low-dose, weight-adjusted heparin (70 U/kg), avoidance of postprocedural heparin, and early vascular sheath removal. Heparin integrin subunit alpha 2b Homo sapiens